USP20 antibody

Synonyms:Deubiquitinating enzyme 20 antibody, hVDU2 antibody, KIAA1003 antibody, LSFR3A antibody, Ubiquitin thiolesterase 20 antibody, USP20 antibody, VDU2 antibody
Catalogue No.:FNab09317Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IHC, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
  • CITATIONS
Product Name
USP20 antibody
Catalogue No.
FNab09317
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
ubiquitin specific peptidase 20
Alternative Names
Deubiquitinating enzyme 20 antibody, hVDU2 antibody, KIAA1003 antibody, LSFR3A antibody, Ubiquitin thiolesterase 20 antibody, USP20 antibody, VDU2 antibody
UniProt ID
Q9Y2K6
Observed MW
110 kDa
Application
Tested Applications
ELISA, WB, IHC, IP
Recommended dilution
WB: 1:200-1:2000; IHC: 1:20-1:200;IP: 1:200-1:2000
Validated Images
HepG2 cells were subjected to SDS PAGE followed by western blot with FNab09317(USP20 antibody) at dilution of 1:400
IP Result of anti-USP20 (IP:FNab09317, 4ug; Detection:FNab09317 1:500) with HeLa cells lysate 1200ug.
Immunohistochemistry of paraffin-embedded human kidney using FNab09317(USP20 antibody) at dilution of 1:50
Background
Deubiquitinating enzyme involved in beta-2 adrenergic receptor(ADRB2) recycling. Acts as a regulator of G-protein coupled receptor(GPCR) signaling by mediating the deubiquitination beta-2 adrenergic receptor(ADRB2). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta-arrestins, possibly leading to beta-arrestins deubiquitination and disengagement from ADRB2. This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Deubiquitinates HIF1A, leading to stabilize HIF1A and enhance HIF1A-mediated activity. Mediates deubiquitination of both 'Lys-48'-and 'Lys-63'-linked polyubiquitin chains.